Track record

To date, HYPERION Life Sciences Ltd has mainly supported European, North-American, Japanese and Latin American small & mid-sized companies from US$ 1 million up to US$10 billion annual turnover, willing to strengthen their activities in Europe, North and South America, Japan and/or Emerging Markets